Trigeminal nerve stimulation for Parkinson's motor symptoms
Part of Brain & nervous system clinical trials.
This trial tests whether a gentle electrical stimulation on the forehead (trigeminal nerve) can improve movement problems in people with Parkinson's disease. It is designed for people who are already on stable Parkinson's medication.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Diagnosed with Parkinson's disease by a neurologist
- Between 40 and 80 years old
- On stable Parkinson's medication for at least 1 month
- Able to walk and have no major balance or gait issues from other causes
- No history of epilepsy, brain tumors, or serious psychiatric disorders
- Willing to use the stimulation device and complete study assessments
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a non-invasive brain stimulation technique (using electrical currents applied through the scalp) aimed at the subthalamic nucleus—a brain region involved in movement control—to help reduce both movement-related symptoms (like tremor and stiffness) and non-movement symptoms (like mood and sleep problems) in people with Parkinson's disease.
This study compares different schedules of a non-invasive brain stimulation treatment (called tTIS) to standard medication for Parkinson's disease. It aims to find the best timing for tTIS to improve motor symptoms.
This trial uses a new type of non-invasive brain stimulation to target a deep brain area that controls movement. It aims to improve motor symptoms like stiffness and slowness in people with Parkinson's disease, without needing surgery.
This study tests a non-invasive nerve stimulation device for reducing tremors in people with Parkinson's disease or essential tremor. It follows up participants from a previous trial to see if benefits last up to 24 months.
This trial tests whether a non-invasive nerve stimulation device (taVNS) worn on the ear can protect brain cells and slow Parkinson's disease progression in early-stage patients. It is for people who have been diagnosed within the last 3 years and are already on standard medication.
This study tests whether a gentle nerve stimulation on the ear (taVNS) can improve movement symptoms in Parkinson's disease. It aims to understand how this stimulation affects the brain.
Hear when a new Parkinson's Disease (PD) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.